Leerink Swann and Company Appoints Joshua Schimmer, M.D. as Biotechnology Analyst

BOSTON--(BUSINESS WIRE)--Healthcare investment bank Leerink Swann announced that Joshua Schimmer, M.D. has joined the firm as Managing Director, Biotechnology Analyst. Dr. Schimmer will cover mid- and large-cap biotechnology companies for the Firm.